Dean Wingerchuk, MD
Enriched profileProfessor and Chair of the Department of Neurology; Eugene and Marcia Applebaum Professor of Neurosciences · Mayo Clinic
Dean Wingerchuk is Professor and Chair of the Department of Neurology; Eugene and Marcia Applebaum Professor of Neurosciences at Mayo Clinic. OpenAlex indexes 346 publications with 35,706 citations (h-index 72); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 21 Oct 2026
Dean Wingerchuk, M.D., is Professor and Chair of the Department of Neurology at Mayo Clinic, Phoenix/Scottsdale, Arizona. The public record shows 346 publications with 35,706 citations (h-index 72), centered on Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Ocular Diseases and Behçet’s Syndrome. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 17 companies.
- Most recent indexed publication: 2026 · Neurology(R) neuroimmunology & neuroinflammation
- Top research focus: Multiple Sclerosis Research Studies
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 17 companies
Generated from the cited public record · current as of 21 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 8 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 197.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 21 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Maintenance Plasma Exchange for Neuromyelitis Optica
Sponsor: Mayo Clinic
- Aspirin for Treatment of Multiple Sclerosis-Related Fatigue
Sponsor: Mayo Clinic
- A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)
Sponsor: University of California, Los Angeles
Industry payments
Updated 21 Oct 2026
17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year202527 payments$24,593openpaymentsdata.cms.gov ↗
- UCB SAProgram year20256 payments$12,500openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year20252 payments$11,397openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
57.5%Gabapentinoids29.2%Gabapentin100%Part D≥12 patientsPotassium Channel Blocker17.5%Dalfampridine Er100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
27.5%Interleukin inhibitors15.8%Enspryng100%Part D<11 patientsSphingosine 1-phosphate Receptor Modulator11.7%Fingolimod100%Part D<11 patientsMusculoskeletal
15%gamma-Aminobutyric Acid-ergic Agonist15%Baclofen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 21 Oct 2026
1 congress contribution (2022) across AMCP per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 21 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Astrocytic and Axonal Injury Biomarkers in AQP4 Antibody-Positive NMOSD: Insights From PREVENT and CHAMPION-NMOSD.
Neurology(R) neuroimmunology & neuroinflammation
Clinical Trial2026 - Cerebellar Involvement in Attacks of Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder.
Neurology(R) neuroimmunology & neuroinflammation
Article2025 - Alterations in Aquaporin-4-IgG Serostatus in 986 Patients: A Laboratory-Based Longitudinal Analysis.
Annals of neurology
Article2023
Most-cited works
by citation count (OpenAlex)- 01International consensus diagnostic criteria for neuromyelitis optica spectrum disordersArticle4,638 citations2015
- 02A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosisArticle3,243 citations2004
- 03Revised diagnostic criteria for neuromyelitis opticaArticle2,574 citations2006
- 04The spectrum of neuromyelitis opticaArticle2,184 citations2007
- 05The clinical course of neuromyelitis optica (Devic’s syndrome)Article1,822 citations1999
Network
Updated 21 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 21 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/dean-wingerchuk-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
alumniassociation.mayo.edu
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →alumniassociation.mayo.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 21 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →college.mayo.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →college.mayo.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →college.mayo.edu ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aan.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →college.mayo.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu ↗
Secondary affiliations
appointments beyond the home institution- Director
Mayo Clinic Division of Multiple Sclerosis and Autoimmune Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →college.mayo.edu ↗ - Program Director
Multiple Sclerosis and Autoimmune Neurology Fellowship, Mayo Clinic Arizona
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →college.mayo.edu ↗ - Director
Mayo Clinic Arizona Evidence-Based Research, Training, and Informatics (MERIT) Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →college.mayo.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
Ayalew Tefferi, MD
Mayo Clinic
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine